Barozzi, Nadia, Peeters, GMEE Geeske and Tett, Susan E. (2015) Actions following adverse drug events – how do these influence uptake and utilisation of newer and/or similar medications. BMC Health Services Research, 15 498: . doi:10.1186/s12913-015-1165-9
Barozzi, Nadia, Sketris, Ingrid, Cooke, Charmaine and Tett, Susan (2009) Comparison of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 (COX-2)inhibitors use in Australia and Nova Scotia (Canada). British Journal of Clinical Pharmacology, 68 1: 106-115. doi:10.1111/j.1365-2125.2009.03410.x
Barozzi, N. and Tett, S. E. (2009) Perceived barriers to paracetamol (acetaminophen)prescribing, especially following rofecoxib withdrawal from the market. Clinical Rheumatology, 28 5: 509-519. doi:10.1007/s10067-008-1077-8
Barozzi, N. and Tett, S. E. (2009) Gastroprotective drugs in Australia: Utilization patterns between 1997 and 2006 in relation to NSAID prescribing. Clinical Therapeutics, 31 4: 849-861. doi:10.1016/j.clinthera.2009.04.012
Barozzi, Nardia and Tett, Susan E. (2008) Non-steroidal anti-inflammatory drugs, Cyclooxygenase-2 inhibitors and paracetamol use in Queensland and in the whole of Australia. BMC Health Services Research, 8 Article Number: 196: 196-1-196-9. doi:10.1186/1472-6963-8-196
Abdel-Aal, Abu-Baker M., Batzloff, Michael R., Fujita, Yoshio, Barozzi, Nadia, Faria, Andres, Simerska, Pavla, Moyle, Peter M., Good, Michael F. and Toth, Istvan (2008) Structure-activity relationship of a series of synthetic lipopeptide self-adjuvanting group A streptococcal vaccine candidates. Journal of Medicinal Chemistry, 51 1: 167-172. doi:10.1021/jm701091d
Barozzi, N. and Tett, S. E. (2007) Cox-2 inhibitor influence on non-steroidal antiinflammatory drug (NSAIDs) and paracetamol use in 6 countries. Pharmacoepidemiology And Drug Safety, 16 s2: S80-S80. doi:10.1002/pds.1461
Barozzi, N. and Tett, S. E. (2007) What happened to the prescribing of other COX-2 inhibitors, paracetamol and non-steroidal anti-inflammatory drugs when rofecoxib was withdrawn in Australia?. Pharmacoepidemiology and Drug Safety, 16 11: 1184-1191. doi:10.1002/pds.1451
Olive, Colleen, Ho, Mei‐Fong, Dyer, Joanne, Lincoln, Douglas, Barozzi, Nadia, Toth, Istvan and Good, Michael F. (2006) Immunization with a tetraepitopic lipid core peptide vaccine construct induces broadly protective immune responses against group A streptococcus. Journal of Infectious Diseases, 193 12: 1666-1676. doi:10.1086/504266
Barozzi, N. and Tett, S.E. (2007). Perceived barriers to acetaminophen prescribing, especially following rofecoxib withdrawal from the market. In: Abstracts : Fourth Canadian Therapeutics Congress. 4th Canadian Therapeutics Congress, Halifax, Nova Scotia, Canada, (e152-e152). 27-30 May 2007.
Barozzi, N. and Tett, S. E. (2006). Evaluating how guidelines for replacement therapy were implemented following withdrawal of rofecoxib. In: Using Evidence: Using Guidelines. The National Institute of Clinical Studies Using Evidence: Using, Melbourne, (111-111). 19-20 October 2006.
Barozzi, N. and Tett, S. E. (2006). How did rofecoxib withdrawal influence overall non-steroidal anti-inflammatory drug (NSAIDs) and paracetamol prescribing in Australia?. In: Final program and abstract book: National Medicines Symposium 2006. Quality Use of Medicines: Balancing Beliefs, Benefits and Harms, Canberra / National Convention Centre, (46-46). 7-9 June 2006.
Moyle, Peter Michael, Olive, Colleen, Karpati, Levente, Barozzi, Nadia, Ho, Mei-Fong, Dyer, Joanne, Sun, Hsien Kuo, Good, Michael and Toth, Istvan (2006). Synthesis and immunological evaluation of M protein targeted tetra-valent and tri-valent group A streptococcal vaccine candidates based on the lipid-core peptide system. In: International Journal of Peptide Research and Therapeutics: Proceedings of the 6th Australian Peptide Conference. 6th Australian Peptide Conference, Whitsunday Islands, Australia, (317-326). 9-14 October, 2005. doi:10.1007/s10989-006-9021-8
Barozzi, N. and Tett, S. E. (2006). Non-steroidal anti-inflammatory drug prescription in relation to the prescribing of gastroprotective drugs in Australia. In: Ronald D. Mann, Abstracts: 22nd International conference on Pharmacoepidemiology & therapeutic Risk Management. 22nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Lisbon, Portugal, (S158-S158). 24-27 August 2006. doi:10.1002/pds.1295
Barozzi, N. and Tett, S.E. (2005). Use of non-selective non-steroidal anti-inflammatory drugs (NSAID), COX-2 inhibitors (COX-2) and paracetamol. In: E.A. Davis and C.G. Sobey, Program & Abstracts: Joint Meeting of ASCEPT and APSA 2005. Joint Meeting of ASCEPT and APSA, Melbourne, (151). 4-7 Dec. 2005.
Nadia Barozzi (2008). Improving the use of prescription medicines : exploration of international comparisons of utilisation and other strategies to influence more rational use of specific medicines PhD Thesis, School of Pharmacy, The University of Queensland.